latest life
.cambridge's bluebird bio licenses delivery tech to novartis, gsk .
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment. .
u.s.
.
copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.